Early Treatment Shows Benefit in Infants With Presymptomatic Genetic Disease

By News Health
3 hours Ago

(MedPage Today) — Infants up to 6 weeks old with genetically diagnosed presymptomatic spinal muscular atrophy (SMA) treated with oral risdiplam (Evrysdi) appeared to have better functional and survival outcomes compared with a natural history…

Source link : https://www.medpagetoday.com/neurology/generalneurology/116978

Author :

Publish date : 2025-08-13 21:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Early ADHD Treatment Tied to Less Risk of Crime, Car Accidents

Quitting Smoking Tied to Better Odds of Recovery From Other Addictions

‘Makes No Sense': Experts Push Back On RFK Jr.’s Doubts About Hepatitis B Vaccine

No Chemo Benefit in Older Women With High-Risk HR-Positive Breast Cancer

GLP-1 Drugs May Hold Benefit in Painful Skin Disease

Want to Make America Healthy? Dump RFK Jr., New Public Health Group Says